Type 2 diabetes

Feinstein doc eyes telehealth for Hispanic diabetes

By GREGORY ZELLER // It’s not precisely the Telemundo of telemedicine, but a Long Island scientist will spend some $3 million of the Patient-Centered Outcomes Research Institute’s money exploring telehealth protocols for Hispanic diabetes patients. The PCORI, a government-funded (but non-government) Washington-based organization that supports and investigates various medical treatments, is backing Feinstein Institute for Medical Research professor Renee Pekmezaris’ study of home telemonitoring for Hispanic-community patients living with type 2 diabetes, the most common…


Schein inks distribution deal for diabetes products

A new U.S. distribution agreement puts a Long Island healthcare-products stalwart in the thick of the fight against type 2 diabetes. Global medical-technology provider Medtronic has selected Henry Schein Medical, a subsidiary of Melville-based Henry Schein Inc., as its exclusive distributor of selected diabetes products to primary-care physicians in the United States. The deal, terms undisclosed, will introduce Schein customers to Medtronic’s cutting-edge solutions for people with Diabetes mellitus type 2, the most common form…